Segers J M, Boedts D
Acta Otorhinolaryngol Belg. 1975;29(5):814-21.
Thirty Ménière patients were treated with betahistine hydrochlorid for an average period of 17 months. The majority of them had been resistent to every previous treatment. The results of this new treatment were very gratifying with respect to the attacks of vertigo and the accompanying neuro-vegetative symptoms. The tinnitus aurium proved to be resistent, whereas the auditory acuity was significantly improved in 7 patients. Early treatment with this product at the first signs of Ménière's disease is very likely to hold up the progressive degradation of auditory acuity, during the further spontaneous evolution of the disease.
30 名梅尼埃病患者接受了盐酸倍他司汀治疗，平均治疗时长为 17 个月。他们中的大多数人对之前的各种治疗均有抵抗性。这种新治疗方法在眩晕发作及伴随的神经植物性症状方面取得了非常令人满意的效果。耳鸣被证明具有抵抗性，而 7 名患者的听力显著改善。在梅尼埃病最初症状出现时就使用该产品进行早期治疗，很可能在疾病进一步自然发展过程中阻止听力的渐进性退化。
